Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17Mar 30, 2022
Innovation
Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-17-NI-007Jul 07, 2017
Biologics
Pharma Revs Up Cancer-Fighting CAR T-Cell Therapy
Emilie Branch
Pharma's Almanac
MCP-M06-17-NI-001Jun 08, 2017